LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Increased Neuronal Activity Stimulates Spread of Tau Proteins in the Brain

By LabMedica International staff writers
Posted on 04 Aug 2016
Print article
Image: In this photomicrograph, the color orange indicates where tau protein has traveled from one neuron to another (Photo courtesy of Dr. Karen E. Duff, Columbia University Medical Center).
Image: In this photomicrograph, the color orange indicates where tau protein has traveled from one neuron to another (Photo courtesy of Dr. Karen E. Duff, Columbia University Medical Center).
Neurodegenerative disease researchers have found that tau proteins released from donor neurons can transfer to recipient cells via the medium, suggesting that at least one mechanism by which tau can transfer in the brain is via the extracellular space.

Tau proteins are proteins that stabilize microtubules. They are abundant in neurons of the central nervous system and are less common elsewhere, but are also expressed at very low levels in central nervous system astrocytes and oligodendrocytes. Pathologies and dementias of the nervous system such as Alzheimer's disease and Parkinson's disease are associated with tau proteins that have become defective and no longer stabilize microtubules properly.

Investigators at Columbia University Medical Center (New York, NY, USA) reported in the June 20, 2016, online edition of the journal Nature Neuroscience that they had used optogenetic and chemogenetic approaches to show that increased neuronal activity stimulated the release of tau in vitro and enhanced tau pathology in vivo.

"These findings suggest that clinical trials testing treatments that increase brain activity, such as deep brain stimulation, should be monitored carefully in people with neurodegenerative diseases," said senior author Dr. Karen Duff, professor of pathology and cell biology at the Columbia University Medical Center. "By learning how tau spreads, we may be able to stop it from jumping from neuron to neuron. This would prevent the disease from spreading to other regions of the brain, which is associated with more severe dementia. This finding has important clinical implications. When tau is released into the extracellular space, it would be much easer to target the protein with therapeutic agents, such as antibodies, than if it had remained in the neuron."

Related Links:
Columbia University Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more